药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Ponatinib.
Glucosamine
Teriparatide
The therapeutic efficacy of Teriparatide can be decreased when used in combination with Ponatinib.
Glucosamine
Parathyroid hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Ponatinib.
Glucosamine
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Ponatinib.
Glucosamine
Tiratricol
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Ponatinib.
Glucosamine
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Ponatinib.
Glucosamine
Tedizolid phosphate
The risk or severity of myelosuppression can be increased when Ponatinib is combined with Tedizolid phosphate.
Glucosamine
Emapalumab
The metabolism of Ponatinib can be increased when combined with Emapalumab.
Glucosamine
Siltuximab
The metabolism of Ponatinib can be increased when combined with Siltuximab.
Glucosamine
Secukinumab
The metabolism of Ponatinib can be increased when combined with Secukinumab.
Glucosamine
Certolizumab pegol
The metabolism of Ponatinib can be increased when combined with Certolizumab pegol.
Glucosamine
Golimumab
The metabolism of Ponatinib can be increased when combined with Golimumab.
Glucosamine
Rilonacept
The metabolism of Ponatinib can be increased when combined with Rilonacept.
Glucosamine
Tocilizumab
The metabolism of Ponatinib can be increased when combined with Tocilizumab.
Glucosamine
Canakinumab
The metabolism of Ponatinib can be increased when combined with Canakinumab.
Glucosamine
Afelimomab
The metabolism of Ponatinib can be increased when combined with Afelimomab.
Glucosamine
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Ponatinib.
Glucosamine
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Ponatinib.
Glucosamine
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Ponatinib.
Glucosamine
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Ponatinib.